JP Morgan Chase
CNTB

JP Morgan Chase’s Connect Biopharma Holdings CNTB Stock Holding History

JP Morgan Chase’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
11,718
+11,597
+9,584% +$28.1K ﹤0.01% 6633
2026
Q1 		$351 Hold
121
– – ﹤0.01% 7210
2025
Q4 		$341 Hold
121
– – ﹤0.01% 7113
2025
Q3 		$179 Hold
121
– – ﹤0.01% 7124
2025
Q2 		$121 Hold
121
– – ﹤0.01% 6817
2025
Q1 		$67 Hold
121
– – ﹤0.01% 6931
2024
Q4 		$167 Hold
121
– – ﹤0.01% 6935
2024
Q3 		$172 Hold
121
– – ﹤0.01% 6922
2024
Q2 		$184 Hold
121
– – ﹤0.01% 6798
2024
Q1 		$211 Hold
121
– – ﹤0.01% 6803
2023
Q4 		$143 Sell
121
-23,411
-99% -$27.8K ﹤0.01% 7087
2023
Q3 		$18.2K Sell
23,532
-24,840
-51% -$22.6K ﹤0.01% 6092
2023
Q2 		$53.7K Sell
48,372
-30,175
-38% -$33.8K ﹤0.01% 5696
2023
Q1 		$79K Buy
78,547
+72,987
+1,313% +$79.6K ﹤0.01% 5530
2022
Q4 		$4K Buy
5,560
+2,490
+81% +$2.05K ﹤0.01% 6191
2022
Q3 		$4K Buy
3,070
+2,818
+1,118% +$3.39K ﹤0.01% 6128
2022
Q2 		$0 Sell
252
-3,668
-94% -$5.4K ﹤0.01% 6511
2022
Q1 		$12K Buy
3,920
+1,052
+37% +$4.44K ﹤0.01% 6172
2021
Q4 		$15K Buy
+2,868
New +$31.9K ﹤0.01% 6267

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

JP Morgan Chase's CNTB Position: Q2 2026 in Review

JP Morgan Chase increased its Connect Biopharma Holdings (CNTB) stake by 9,584% in Q2 2026, buying an estimated $28.1K and bringing the position to 11,718 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6633.

JP Morgan Chase first reported a position in CNTB in Q4 2021 and has held it in 19 quarters since. The position peaked at $79K in Q1 2023. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • JP Morgan Chase held 11,718 shares of Connect Biopharma Holdings worth $27.9K as of Q2 2026.
  • JP Morgan Chase bought 11,597 Connect Biopharma Holdings shares in Q2 2026, an estimated $28.1K.
  • Connect Biopharma Holdings made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6633 holding.
  • JP Morgan Chase first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Connect Biopharma Holdings position peaked at $79K in Q1 2023.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.